Cardiomyopathies-past, present, future.
作者信息
Maisch Bernhard, Bauersachs Johann
机构信息
Philipps-Universität Marburg, Feldbergstr. 45, 35043, Marburg, Germany.
Klinik für Kardiologie und Angiologie, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
出版信息
Herz. 2020 May;45(3):209-211. doi: 10.1007/s00059-020-04905-3.
Abstract
摘要
相似文献
1
Cardiomyopathies-past, present, future.心肌病——过去、现在与未来
Herz. 2020 May;45(3):209-211. doi: 10.1007/s00059-020-04905-3.
2
The MOGE(S) classification for cardiomyopathies: current status and future outlook.心肌疾病的 MOGE(S)分类：现状与展望。
Heart Fail Rev. 2017 Nov;22(6):743-752. doi: 10.1007/s10741-017-9641-4.
3
Insights into the Classification of Cardiomyopathies: Past, Present, and Future Directions.心肌病分类的见解：过去、现在和未来方向
Clinics (Sao Paulo). 2021 Mar 26;76:e2808. doi: 10.6061/clinics/2021/e2808. eCollection 2021.
4
Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC).遗传性扩张型和肥厚型心肌病的靶向治疗：从分子机制到治疗靶点。心力衰竭协会（HFA）和欧洲心脏病学会（ESC）心肌功能工作组的立场文件。
Eur J Heart Fail. 2022 Mar;24(3):406-420. doi: 10.1002/ejhf.2414. Epub 2022 Jan 14.
5
The MOGE(S) classification : A TNM-like classification for cardiomyopathies.MOGE(S) 分类：一种类似于TNM的心肌病分类方法。
Herz. 2016 Sep;41(6):503-6. doi: 10.1007/s00059-015-4394-0. Epub 2016 Jan 25.
6
Twenty years of progress and beckoning frontiers in cardiovascular pathology: cardiomyopathies.心血管病理学二十年的进展与前沿领域：心肌病
Cardiovasc Pathol. 2005 Jul-Aug;14(4):165-9. doi: 10.1016/j.carpath.2005.03.008.
7
The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology.心内膜心肌活检在心血管疾病管理中的作用：美国心脏协会、美国心脏病学会和欧洲心脏病学会的科学声明。得到美国心力衰竭学会和欧洲心脏病学会心力衰竭协会认可。
J Am Coll Cardiol. 2007 Nov 6;50(19):1914-31. doi: 10.1016/j.jacc.2007.09.008.
8
Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology.致心律失常性右室发育不良/心肌病的诊断。欧洲心脏病学会心肌和心包疾病工作组及国际心脏病学会和联合会心肌病科学委员会特别工作组。
Br Heart J. 1994 Mar;71(3):215-8. doi: 10.1136/hrt.71.3.215.
9
[Classification of cardiomyopathies and indication for endomyocardial biopsy revisited].[心肌病的分类及心内膜心肌活检指征再探讨]
Herz. 2009 Feb;34(1):55-62. doi: 10.1007/s00059-009-3195-8.
10
[Cardiovascular diseases: present and future based on molecular biology].[心血管疾病：基于分子生物学的现状与未来]
Rev Invest Clin. 2003 Mar-Apr;55(2):155-60.
引用本文的文献
1
A Machine Learning Approach to Gene Expression in Hypertrophic Cardiomyopathy.一种用于肥厚型心肌病基因表达的机器学习方法。
Pharmaceuticals (Basel). 2024 Oct 12;17(10):1364. doi: 10.3390/ph17101364.
本文引用的文献
1
Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy.围生期心肌病的病理生理学、诊断和治疗：欧洲心脏病学会心力衰竭协会围生期心肌病研究组的立场声明。
Eur J Heart Fail. 2019 Jul;21(7):827-843. doi: 10.1002/ejhf.1493. Epub 2019 Jun 27.
2
Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology.心肌病心力衰竭：欧洲心脏病学会心力衰竭协会立场文件。
Eur J Heart Fail. 2019 May;21(5):553-576. doi: 10.1002/ejhf.1461. Epub 2019 Apr 16.
3
Cardiomyopathies: classification, diagnosis, and treatment.心肌病：分类、诊断和治疗。
Heart Fail Clin. 2012 Jan;8(1):53-78. doi: 10.1016/j.hfc.2011.08.014.
4
[Classification of cardiomyopathies and indication for endomyocardial biopsy revisited].[心肌病的分类及心内膜心肌活检指征再探讨]
Herz. 2009 Feb;34(1):55-62. doi: 10.1007/s00059-009-3195-8.
5
Myocarditis.心肌炎
Cal State J Med. 1904 Dec;2(12):369-71.
6
The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology.心内膜心肌活检在心血管疾病管理中的作用：美国心脏协会、美国心脏病学会和欧洲心脏病学会的科学声明。
Circulation. 2007 Nov 6;116(19):2216-33. doi: 10.1161/CIRCULATIONAHA.107.186093. Epub 2007 Oct 24.
7
Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases.心肌病的分类：欧洲心脏病学会心肌和心包疾病工作组的立场声明
Eur Heart J. 2008 Jan;29(2):270-6. doi: 10.1093/eurheartj/ehm342. Epub 2007 Oct 4.
8
Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.心肌病的当代定义和分类：美国心脏协会临床心脏病学理事会、心力衰竭与移植委员会的科学声明；医疗质量与结果研究及功能基因组学与转化生物学跨学科工作组；以及流行病学与预防理事会。
Circulation. 2006 Apr 11;113(14):1807-16. doi: 10.1161/CIRCULATIONAHA.106.174287. Epub 2006 Mar 27.
9
Clinical and genetic issues in familial dilated cardiomyopathy.家族性扩张型心肌病的临床与遗传学问题
J Am Coll Cardiol. 2005 Apr 5;45(7):969-81. doi: 10.1016/j.jacc.2004.11.066.
10
The cardiomyopathies: a report of fifty cases.
Australas Ann Med. 1960 Nov;9:258-70. doi: 10.1111/imj.1960.9.4.258.
Zotero 插件